Annexon, Inc.
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets disti…
Biotechnology
US, Brisbane [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Annexon, Inc. has no acquisition track records yet.
M&A Deals · History
Annexon, Inc. has no acquisition track records yet.